Genaissance Pharmaceuticals

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response

Phase 3
Completed
Conditions
Interventions
First Posted Date
2006-02-02
Last Posted Date
2008-02-21
Lead Sponsor
Genaissance Pharmaceuticals
Target Recruit Count
410
Registration Number
NCT00285376
Locations
🇺🇸

University of Pennsylvania Department of Psychiatry Mood and Anxiety Disorders Section, Philadelphia, Pennsylvania, United States

🇺🇸

University of Utah health Services Center Dept. of Psychiatry Mood and Anxiety Disorders, Salt Lake City, Utah, United States

🇺🇸

Pharmacology Research Institute, Riverside, California, United States

and more 7 locations
© Copyright 2024. All Rights Reserved by MedPath